Bromide

Bromide

SCHEMBL320636

CCCCCCCCCCCCCC[N+](C)(C)CC.[Br-]

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 12/20 1.00
HSP90AA1 P07900 2/20 1.00
RAD52 P43351 2/20 1.00
HTT P42858 2/20 0.94
KMT2A Q03164 1/20 0.94
ALDH1A1 P00352 1/20 0.60
TP53 P04637 1/20 0.60
CYP3A4 P08684 1/20 0.60
ALOX15 P16050 1/20 0.60
TSHR P16473 1/20 0.60
ALOX12 P18054 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
HIF1A Q16665 1/20 0.60
HSD17B10 Q99714 1/20 0.60
PLA2G1B P04054 1/20 0.58
ATG4B Q9Y4P1 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL31103612 1.00 DNM1 (1.00) DNM1HSP90AA1RAD52HTTKMT2A
Bromide SCHEMBL238105 1.00 DNM1 (1.00) DNM1HSP90AA1RAD52HTTKMT2A
Bromide SCHEMBL11903700 1.00 DNM1 (1.00) DNM1HSP90AA1RAD52HTTKMT2A
Bromide SCHEMBL11546904 1.00 DNM1 (1.00) DNM1HSP90AA1RAD52HTTKMT2A
Bromide SCHEMBL5594917 1.00 DNM1 (1.00) DNM1HSP90AA1RAD52HTTKMT2A
Bromide SCHEMBL60951 1.00 DNM1 (1.00) DNM1HSP90AA1RAD52HTTKMT2A
Mecetronium SCHEMBL60918 1.00 DNM1 (1.00) DNM1HSP90AA1RAD52HTTKMT2A
Mecetronium SCHEMBL675420 1.00 DNM1 (1.00) DNM1HSP90AA1RAD52HTTKMT2A
Bromide SCHEMBL21253152 1.00 DNM1 (1.00) DNM1HSP90AA1RAD52HTTKMT2A
Bromide SCHEMBL31103710 1.00 DNM1 (1.00) DNM1HSP90AA1RAD52HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114920954-B High-strength and high-toughness swelling-resistant supermolecule conductive hydrogel and preparation method and application thereof 广东工业大学 2024-12-06 CN claimed
CN-118790985-A Self-assembled frame structure of two-dimensional material and preparation method thereof 复旦大学 2024-10-18 CN claimed
CN-118639465-A Water-based coating material for plastic-free paper, preparation method and application thereof 广东工业大学 2024-09-13 CN claimed
CN-118140943-A Environment-friendly sterilizing disinfectant and preparation method thereof 江苏爱特福84股份有限公司 2024-06-07 CN claimed
CN-117487142-A High-barrier biodegradable polyester, preparation method thereof and high-barrier biodegradable film 道恩周氏(青岛)复合包装材料有限公司 2024-02-02 CN claimed
CN-115286326-B Anti-mildew greenhouse wall material 山东省寿光蔬菜产业集团有限公司 2023-01-06 CN claimed
CN-115286326-A Anti-mildew greenhouse wall material 山东省寿光蔬菜产业集团有限公司 2022-11-04 CN claimed
CN-114920954-A High-strength-toughness anti-swelling supermolecule conductive hydrogel and preparation method and application thereof 广东工业大学 2022-08-19 CN claimed
CN-109513036-B Collagen material capable of automatically closing antibacterial function under receptor temperature induction 四川大学 2021-04-20 CN claimed
CN-106548828-B A kind of method for improving nano silver wire electrically conducting transparent film conductivity and transmitance 中国科学院宁波材料技术与工程研究所 2017-10-20 CN claimed
EP-2588586-B1 COMPATIBLE MIXTURES OF ANIONIC AND CATIONIC SURFACTANTS DOW GLOBAL TECHNOLOGIES LLC (US) 2016-12-21 EP claimed
US-8586115-B2 Antimicrobial solutions and process related thereto BYOCOAT ENTERPRISES, INC. (US) 2013-11-19 US claimed
US-8557756-B2 Compatible mixtures of anionic and cationic surfactants DOW GLOBAL TECHNOLOGIES LLC (US) 2013-10-15 US claimed
EP-2588586-A1 COMPATIBLE MIXTURES OF ANIONIC AND CATIONIC SURFACTANTS Dow Global Technologies LLC (US) 2013-05-08 EP claimed
US-20120264758-A1 ANTIMICROBIAL SOLUTIONS AND PROCESS RELATED THERETO BYOCOAT ENTERPRISES, INC. (US) 2012-10-18 US claimed
WO-2012005899-A1 COMPATIBLE MIXTURES OF ANIONIC AND CATIONIC SURFACTANTS DOW GLOBAL TECHNOLOGIES LLC (US) 2012-01-12 WO claimed
US-20110319313-A1 COMPATIBLE MIXTURES OF ANIONIC AND CATIONIC SURFACTANTS DOW GLOBAL TECHNOLOGIES LLC 2011-12-29 US claimed
US-12325646-B2 Fertigation water treatment UNIVERSITY OF GUELPH (CA) 2025-06-10 US disclosed
EP-0006271-A1 Washing and softening compositions containing nonionic brightener THE PROCTER & GAMBLE COMPANY (US) 1980-01-09 EP disclosed
EP-0002085-A2 Textile conditioning compositions with low content of cationic guar gum THE PROCTER & GAMBLE COMPANY (US) 1979-05-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120264758-A1 ANTIMICROBIAL SOLUTIONS AND PROCESS RELATED THERETO DAO, AGPS, DDC DNM1 756/4885HSP90AA1 2795/4885RAD52 2884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.